News
Beren Therapeutics Presents Data Supporting the Efficacy of Adrabetadex in Infantile-Onset NPC at 2026 ACMG Clinical Genetics Meeting
March 12, 2026
Press Release
Beren Therapeutics Announces FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann Pick Disease Type C
February 23, 2026
Press Release
Webinar Highlights and Path Forward in NPC
February 1, 2026
Community Updates
Letter to the NPC Community: Filing of Adrabetadex New Drug Application with FDA for Infantile NPC
December 19, 2025
Community Updates
Beren, Through its Subsidiary Mandos, Submits New Drug Application to U.S. FDA for Adrabetadex in Infantile-Onset NPC
December 19, 2025
Press Release
FDA Grants Breakthrough Therapy Designation to Investigational Drug Adrabetadex for Individuals with Infantile-Onset Niemann-Pick Disease Type C
December 9, 2025
Press Release
Data Analyses Show Benefit for Individuals With Infantile-Onset Niemann-Pick Disease Type C Treated With Investigational Drug Adrabetadex
October 9, 2025
Press Release
Community Update — October 2025
October 1, 2025
Community Updates
Mandos Health to Present New Analyses in Niemann-Pick Disease Type C at the 2025 American Neurological Association Annual Meeting
September 12, 2025
Press Release
Community Update — May 2025
May 1, 2025
Community Updates